Ben-Bassat I, Brok-Simoni F, Holtzman F, Ramot B
Med Pediatr Oncol. 1981;9(4):387-91. doi: 10.1002/mpo.2950090412.
Nucleoside phosphorylase (NP) activity was assayed in normal peripheral blood lymphocytes, mature and immature thymocytes fractionated by peanut agglutinability, CLL lymphocytes, and ALL lymphoblasts to determine applicability as an enzymatic cell marker. Circulating lymphocytes had the highest activity, immature thymocytes the lowest, and mature thymocytes were intermediate in NP level. This suggests an increase in NP activity with T-cell maturation. CLL lymphocytes showed very low activity, confirming previous reports. However, the NP activity of the lymphoblasts of 40 patients with B, T, and non-B, non-T ALL was similar to that of normal peripheral blood lymphocytes and could not be used to discriminate between these subgroups of ALL.
对正常外周血淋巴细胞、通过花生凝集性分离的成熟和未成熟胸腺细胞、慢性淋巴细胞白血病(CLL)淋巴细胞以及急性淋巴细胞白血病(ALL)淋巴母细胞进行核苷磷酸化酶(NP)活性测定,以确定其作为酶细胞标志物的适用性。循环淋巴细胞活性最高,未成熟胸腺细胞活性最低,成熟胸腺细胞的NP水平处于中间。这表明随着T细胞成熟,NP活性增加。CLL淋巴细胞活性非常低,证实了先前的报道。然而,40例B、T以及非B、非T ALL患者的淋巴母细胞的NP活性与正常外周血淋巴细胞相似,无法用于区分ALL的这些亚组。